Evidence map›Paper›PMID 30443561›Full record

ArticleBladder cancer (Amsterdam, Netherlands)2018

A Festschrift in Honor of Edward M. Messing, MD, FACS.

Jean V Joseph, Ralph Brasacchio, Chunkit Fung, Jay Reeder, Kevin Bylund, Deepak Sahasrabudhe, Shu Yuan Yeh, Ahmed Ghazi, Patrick Fultz, Deborah Rubens and 34 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Bladder cancer (Amsterdam, Netherlands), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

44 authors.

Jean V JosephUniversity of Rochester Medical Center, Rochester, NY, USA.
Ralph BrasacchioUniversity of Rochester Medical Center, Rochester, NY, USA.
Chunkit FungUniversity of Rochester Medical Center, Rochester, NY, USA.
Jay ReederUniversity of Rochester Medical Center, Rochester, NY, USA.
Kevin BylundUniversity of Rochester Medical Center, Rochester, NY, USA.
Deepak SahasrabudheUniversity of Rochester Medical Center, Rochester, NY, USA.
Shu Yuan YehUniversity of Rochester Medical Center, Rochester, NY, USA.
Ahmed GhaziUniversity of Rochester Medical Center, Rochester, NY, USA.
Patrick FultzUniversity of Rochester Medical Center, Rochester, NY, USA.
Deborah RubensUniversity of Rochester Medical Center, Rochester, NY, USA.
Guan WuUniversity of Rochester Medical Center, Rochester, NY, USA.
Eric SingerRutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Edward SchwarzUniversity of Rochester Medical Center, Rochester, NY, USA.
Supriya MohileUniversity of Rochester Medical Center, Rochester, NY, USA.
James MohlerRoswell Cancer Institute, Buffalo, NY, USA.
Dan TheodorescuCedars Sinai Medical Center, Los Angeles, CA, USA.
Yi Fen LeeUniversity of Rochester Medical Center, Rochester, NY, USA.
Paul OkunieffUF Health Proton Therapy Institute, Gainesville, FL, USA.
David McConkeyJohns Hopkins Greenberg Bladder Cancer Institute, Baltimore, MD, USA.
Hani RashidUniversity of Rochester Medical Center, Rochester, NY, USA.
Chawnshang ChangUniversity of Rochester Medical Center, Rochester, NY, USA.
Yves FradetCHU de Quebec-Hotel-Dieu de Quebec, Quebec, QC, Canada.
Khurshid GuruRoswell Cancer Institute, Buffalo, NY, USA.
Janet KukrejaMD Anderson Cancer Center, Houston, TX, USA.
Gerald SufrinState University of New York at Buffalo, Buffalo, NY, USA.
Yair LotanUT Southwestern Medical Center at Dallas, Dallas, TX, USA.
Howard BaileyUniversity of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Katia NoyesRoswell Cancer Institute, Buffalo, NY, USA.
Seymour SchwartzUniversity of Rochester Medical Center, Rochester, NY, USA.
Kathy RideoutUniversity of Rochester Medical Center, Rochester, NY, USA.
Gennady BratslavskySUNY Upstate Medical University, Syracuse, NY, USA.
Steven C CampbellGlickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Ithaar DerweeshUC San Diego, San Diego, CA, USA.
Per-Anders AbrahamssonLund University, Malmo, Sweden.
Mark SolowayMemorial Healthcare System, Aventura, FL, USA.
Leonard GomellaSidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
Dragan GolijaninLifespan Cancer Institute, Providence, RI, USA.
Robert SvatekUT Health Science Center San Antonio, San Antonio, TX, USA.
Thomas FryeUniversity of Rochester Medical Center, Rochester, NY, USA.
Seth LernerBaylor College of Medicine Medical Center, Houston, TX, USA.
Ganesh PalapattuUniversity of Michigan Medical School, Ann Arbor, MI, USA.
George WildingMD Anderson Cancer Center, Houston, TX, USA.
Michael DrollerMt. Sinai Medical Center, New York, NY, USA.
Donald TrumpVirginia Commonwealth University, Fairfax, VA, USA.

Funding

SWOG Network Group Operations Center of the NCTNU10CA180888 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI DAWN HERSHMAN, PRIMO N. LARA · 2014 to 2026
$152.1M
Regulation and Targeting of CD24 in Bladder CancerR01CA075115 · NCI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI THEODORESCU, DAN · 2003 to 2024
$7.0M
NCI National Clinical Trials Network - Lead Academic Participating SiteUG1CA233324 · NCI · UNIVERSITY OF COLORADO DENVER · PI ANTHONY D ELIAS · 2019 to 2026
$5.2M
Exosomes: A novel mechanism for bladder cancer tumorigenesis and progressionR01CA173986 · NCI · UNIVERSITY OF ROCHESTER · PI LEE, YI-FEN · 2014 to 2018
$1.8M
NCI NIH HHS R01 CA075115NCI NIH HHS R01 CA173986NCI NIH HHS U10 CA180888NCI NIH HHS UG1 CA233324
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID30443561
PMCPMC6226303

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.